Cargando…

HIF1α epigenetically repressed macrophages via CRISPR/Cas9-EZH2 system for enhanced cancer immunotherapy

Immune suppressive microenvironment in tumor emerges as the main obstacle for cancer immunotherapy. In this study, we identified that HIF1α was activated in the tumor associated macrophages and acted as an important factor for the immune suppressive microenvironment. Epigenetically silencing of Hif1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Yan, Zhang, Siyan, Gao, Xiaotong, Yin, Dandan, Wang, Tingting, Li, Zhelong, Wan, Zhuo, Wei, Mengying, Luo, Ying, Yang, Guodong, Liu, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	KeAi Publishing 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905236/ https://www.ncbi.nlm.nih.gov/pubmed/33718668 http://dx.doi.org/10.1016/j.bioactmat.2021.02.008

Ejemplares similares

EZH2 promotes metabolic reprogramming in glioblastomas through epigenetic repression of EAF2-HIF1α signaling
por: Pang, Bo, et al.
Publicado: (2016)

Repressing the repressor: Ezh2 mediates macrophage activation
por: Neele, Annette E., et al.
Publicado: (2018)

Transcriptional repression of PTEN in neural cells using CRISPR/dCas9 epigenetic editing
por: Moses, C., et al.
Publicado: (2020)

Epigenetic repression of the Igk locus by STAT5-mediated Ezh2 recruitment
por: Mandal, Malay, et al.
Publicado: (2011)

Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis
por: Delgado-Olguín, Paul, et al.
Publicado: (2012)

MYCN contributes to the malignant characteristics of erythroleukemia through EZH2-mediated epigenetic repression of p21
por: Liu, Li, et al.
Publicado: (2017)

Targeted epigenetic repression by CRISPR/dSaCas9 suppresses pathogenic DUX4-fl expression in FSHD
por: Himeda, Charis L., et al.
Publicado: (2020)

EZH2-mediated epigenetic repression of DNA repair in promoting breast tumor initiating cells
por: Stefansson, Olafur Andri, et al.
Publicado: (2011)

Chronic myelogenous leukemia cells remodel the bone marrow niche via exosome-mediated transfer of miR-320
por: Gao, Xiaotong, et al.
Publicado: (2019)

Bacterial alginate regulators and phage homologs repress CRISPR-Cas immunity
por: Borges, Adair L., et al.
Publicado: (2020)

Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy
por: Liu, Zaoqu, et al.
Publicado: (2023)

CRISPR/Cas9‑mediated EZH2 knockout suppresses the proliferation and migration of triple‑negative breast cancer cells
por: Mao, Qiqi, et al.
Publicado: (2023)

Exosome‐Based Mitochondrial Delivery of circRNA mSCAR Alleviates Sepsis by Orchestrating Macrophage Activation
por: Fan, Li, et al.
Publicado: (2023)

Adoptive transfer of metabolically reprogrammed macrophages for atherosclerosis treatment in diabetic ApoE(−/-) mice
por: Wang, Tingting, et al.
Publicado: (2022)

CRISPR-Cas in Acinetobacter baumannii Contributes to Antibiotic Susceptibility by Targeting Endogenous AbaI
por: Wang, Yuhang, et al.
Publicado: (2022)

Repurposing endogenous type I CRISPR-Cas systems for programmable gene repression
por: Luo, Michelle L., et al.
Publicado: (2015)

Comparison of CRISPR–Cas9 Tools for Transcriptional Repression and Gene Disruption in the BEVS
por: Bruder, Mark R., et al.
Publicado: (2021)

Novel Epigenetic Techniques Provided by the CRISPR/Cas9 System
por: Xie, Nina, et al.
Publicado: (2018)

Genetic and epigenetic control of gene expression by CRISPR–Cas systems
por: Lo, Albert, et al.
Publicado: (2017)

EZH1 and EZH2 promote skeletal growth by repressing inhibitors of chondrocyte proliferation and hypertrophy
por: Lui, Julian C., et al.
Publicado: (2016)

Inhibition of EZH2 primes the cardiac gene activation via removal of epigenetic repression during human direct cardiac reprogramming
por: Tang, Yawen, et al.
Publicado: (2021)

Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner
por: O’Geen, Henriette, et al.
Publicado: (2019)

Immunotherapy and CRISPR Cas Systems: Potential Cure of COVID-19?
por: He, Xuesong, et al.
Publicado: (2022)

Modular Hydrogel Vaccine for Programmable and Coordinate Elicitation of Cancer Immunotherapy
por: Ji, Panpan, et al.
Publicado: (2023)

EZH2, HIF-1, and Their Inhibitors: An Overview on Pediatric Cancers
por: Papale, Marco, et al.
Publicado: (2018)

CRISPR/Cas9 Technique for Temperature, Drought, and Salinity Stress Responses
por: Li, Xiaohan, et al.
Publicado: (2022)

The Application of CRISPR/Cas9 Technology for Cancer Immunotherapy: Current Status and Problems
por: Wang, Luyao, et al.
Publicado: (2022)

Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system
por: Bikard, David, et al.
Publicado: (2013)

Targeted Chromatinization and Repression of HIV-1 Provirus Transcription with Repurposed CRISPR/Cas9
por: Olson, Alex, et al.
Publicado: (2020)

Epigenetic Footprints of CRISPR/Cas9-Mediated Genome Editing in Plants
por: Lee, Jun Hyung, et al.
Publicado: (2020)

Epigenetic features drastically impact CRISPR–Cas9 efficacy in plants
por: Weiss, Trevor, et al.
Publicado: (2022)

PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression
por: Yang, Liu, et al.
Publicado: (2021)

Group B Streptococcus Cas9 variants provide insight into programmable gene repression and CRISPR-Cas transcriptional effects
por: Gopalakrishna, Kathyayini P., et al.
Publicado: (2023)

Consequences of CRISPR-Cas9-Mediated CFTR Knockout in Human Macrophages
por: Zhang, Shuzhong, et al.
Publicado: (2020)

CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
por: Ghaffari, Sasan, et al.
Publicado: (2021)

Modular Hydrogel Vaccine for Programmable and Coordinate Elicitation of Cancer Immunotherapy (Adv. Sci. 22/2023)
por: Ji, Panpan, et al.
Publicado: (2023)

Reprogramming Immune Cells for Enhanced Cancer Immunotherapy: Targets and Strategies
por: Dong, Yan, et al.
Publicado: (2021)

EZH2 Inhibitors Suppress Colorectal Cancer by Regulating Macrophage Polarization in the Tumor Microenvironment
por: Li, Chen, et al.
Publicado: (2022)

Site-specific recruitment of epigenetic factors with a modular CRISPR/Cas system
por: Anton, Tobias, et al.
Publicado: (2017)

Epigenetic switch reveals CRISPR/Cas9 response to cytosine methylation in plants
por: Raffan, Sarah, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mvtdbf6lu4l69fte1nelephrbb